Abionyx Pharma SA (ABNX) — Capital Reinvestment Ratio

Latest as of December 2022: 0.27x

Abionyx Pharma SA (ABNX) has a Capital Reinvestment Ratio of 0.27x as of December 2022, meaning it reinvests 0% of its operating cash flow (€214.00K) in capital expenditures (€57.00K). See ABNX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.27x
Capex / Operating Cash Flow

Operating Cash Flow

€214.00K
EUR

Capital Expenditures

€57.00K
EUR

Data as of

Dec 2022
Most recent filing

Annual Capital Reinvestment Ratio for Abionyx Pharma SA (None–None)

Year-by-year Capital Reinvestment Ratio for Abionyx Pharma SA from None to None. For live market cap and broader valuation context, see Abionyx Pharma SA stock valuation.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow